Aquestive Therapeutics Receives Notification from FDA that It Will Not Be Ready to Take Action by December 23, 2021 for the Company’s NDA for…
Women In Bio Elects Dr. Azurii Collier as 2022 President-Elect
Zosano Appoints Industry Veteran, Kathy McGee, to its Board of Directors
SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe
Originally posted here:
SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe
NexImmune Appoints Healthcare Innovator Grant Verstandig as New Board Member
Emerald Bioscience Launches Rebrand Including Name Change to Skye Bioscience
Here is the original post:
Emerald Bioscience Launches Rebrand Including Name Change to Skye Bioscience
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
Originally posted here:
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
Novan Provides Enrollment Update and Announces New Corporate Headquarters
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences
Bespoke Extracts Increases Conversion Price of Outstanding Discount Convertible Debentures
Read the original here:
Bespoke Extracts Increases Conversion Price of Outstanding Discount Convertible Debentures
Neuropathix, Inc. Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant
Theratechnologies Announces Closing of US$46 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
Capricor Therapeutics Announces Publication Demonstrating Methods for Enhanced Potency of Cardiosphere-Derived Exosomes
VIRBAC:2020 annual revenue shows strong growth of +5.7% at constant exchange rates and scope (+3.2% at constant rates)
Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference
Tauriga Sciences Inc. to Construct Product Showroom Within its New Corporate Headquarters
Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer
Here is the original post:
Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer
Agenus to Participate in B. Riley Securities’ Oncology Investor Conference
See the rest here:
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
Go here to see the original:
Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference